IGF1 as a Target Gene in Ewing's Sarcoma
Author Information
Author(s): Cironi Luisa, Riggi Nicolò, Provero Paolo, Wolf Natalie, Suvà Mario-Luca, Suvà Domizio, Kindler Vincent, Stamenkovic Ivan
Primary Institution: Division of Experimental Pathology, Institute of Pathology CHUV, University of Lausanne, Lausanne, Switzerland
Hypothesis
Do Ewing's sarcoma fusion proteins activate the IGF1 promoter in mesenchymal progenitor cells?
Conclusion
The study found that IGF1 induction may be a common mechanism for Ewing's sarcoma fusion proteins in tumor development.
Supporting Evidence
- EWS-FLI-1, EWS-ERG, and FUS-ERG fusion proteins were shown to activate the IGF1 promoter.
- Only 14% of genes induced by the fusion proteins were shared among them.
- The study demonstrated that IGF1 is a direct target gene of Ewing's sarcoma fusion proteins.
Takeaway
Ewing's sarcoma proteins can turn on a gene called IGF1, which helps tumors grow, in certain stem cells.
Methodology
The researchers compared the expression of Ewing's sarcoma fusion proteins in mouse progenitor cells and analyzed gene expression changes.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily focused on mouse progenitor cells, which may not fully represent human biology.
Participant Demographics
Mouse mesenchymal progenitor cells were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website